Study identifier:NIS-OFR-FAS-2007/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Observational usage study of Faslodex in patients suffering from initial breast cancer in France
Breast Cancer
-
No
-
Female
217
Observational
N/A
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|---|
1 Patients suffering from initial breast cancer, treated with Faslodex, treatment which was stopped during 2007 | - |